Allspring Global Investments
OKUR

Allspring Global Investments’s OnKure Therapeutics OKUR Stock Holding History

Allspring Global Investments’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-53
Closed -$4K – 2786
2023
Q3 		$4K Buy
+53
New +$3.6K ﹤0.01% 2684
2022
Q2 		– Sell
-227
Closed -$6K – 2971
2022
Q1 		$6K Hold
227
– – ﹤0.01% 2978
2021
Q4 		$19K Buy
+227
New +$16.7K ﹤0.01% 2903

Other funds holding OKUR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Allspring Global Investments's OKUR Position: Q4 2023 in Review

Allspring Global Investments sold out of OnKure Therapeutics (OKUR) in Q4 2023, closing a stake of 53 shares — an estimated $4K sold.

Allspring Global Investments first reported a position in OKUR in Q4 2021 and held it in 3 quarters. The position peaked at $19K in Q4 2021. 68 funds tracked by Wall St. Rank hold OKUR as of Q4 2023.

  • Allspring Global Investments reported no remaining OnKure Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Allspring Global Investments sold 53 OnKure Therapeutics shares in Q4 2023, an estimated $4K.
  • Allspring Global Investments first reported a position in OnKure Therapeutics in Q4 2021 and held it in 3 quarters.
  • Allspring Global Investments's OnKure Therapeutics position peaked at $19K in Q4 2021.
  • 68 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.